Arkolith/Insider Trading/ALRN/Form 4

Windsor James Brian

President and CEOAileron Therapeutics, Inc. (ALRN) · full profile →Form 4 · filed Dec 9, 2024
Net Buying
Open-Market Buys
$898
Open-Market Sells
$0
Net Open-Market Flow
$898
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2024Buy(P)239$2.24$535239
Dec 5, 2024Buy(P)161$2.25$362161

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-134522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML